Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
APONTIS PHARMA AG (APPH) Stock Price & Analysis
3 Followers
APPH Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.03 - €9.26
Previous Close€8.8
Volume89.00
Average Volume (3M)6.38K
Market Cap
€74.80M
Enterprise Value€38.45M
Total Cash (Recent Filing)€36.35M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)-6.5
Beta0.92
Next Earnings
Aug 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.36
Shares Outstanding8,500,000
10 Day Avg. Volume4,675
30 Day Avg. Volume6,379
Standard Deviation0.21
R-Squared0.14
Alpha0.00687
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€20.00Price Target Upside127.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.02% Mutual Funds
0.00% Other Institutional Investors
99.98% Public Companies and
Individual Investors
APPH FAQ
What was APONTIS PHARMA AG’s price range in the past 12 months?
APONTIS PHARMA AG lowest stock price was €3.03 and its highest was €9.26 in the past 12 months.
What is APONTIS PHARMA AG’s market cap?
Currently, no data Available
When is APONTIS PHARMA AG’s upcoming earnings report date?
APONTIS PHARMA AG’s upcoming earnings report date is Aug 09, 2024 which is in 86 days.
How were APONTIS PHARMA AG’s earnings last quarter?
Currently, no data Available
Is APONTIS PHARMA AG overvalued?
According to Wall Street analysts APONTIS PHARMA AG’s price is currently Undervalued.
Does APONTIS PHARMA AG pay dividends?
APONTIS PHARMA AG does not currently pay dividends.
What is APONTIS PHARMA AG’s EPS estimate?
APONTIS PHARMA AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does APONTIS PHARMA AG have?
APONTIS PHARMA AG has 8,500,000 shares outstanding.
What happened to APONTIS PHARMA AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of APONTIS PHARMA AG?
Currently, no hedge funds are holding shares in DE:APPH
---
APONTIS PHARMA AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€20.00 (127.79% Upside)
€20.00 (127.79% Upside)
Insider Transactions
Bought Shares
Worth €36.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.56%
12-Months-Change
Fundamentals
Return on Equity
-31.47%
Trailing 12-Months
Asset Growth
-4.00%
Trailing 12-Months
Company Description
APONTIS PHARMA AG
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. Single Pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes and sells a broad portfolio of Single Pills and other pharmaceutical products, with a special focus on cardiovascular diseases.
---
APPH Stock 12 Month Forecast
Average Price Target
€20.00
▲(127.79% Upside)
Technical Analysis
Best Analysts Covering APPH
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
+14.65%
reiterated a buy rating last month
Copying Christian Ehmann's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +14.65% per trade.
---